Bringing the fundamentals into focus…
Back to SOPHiA GENETICS SA
How SOPHiA GENETICS SA stacks up
SOPH · against 430 other Healthcare companies of similar size
Growth
60/ 100
Above the middle of the pack.
Ranked #150 of 431 · scores higher than 65% of peers
Bars: peers in each 10-point band of the growth score39 peers with a growth score of 60–69, including SOPH · Click a bar to see the companies
Why growth scores 60?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 77% of peers. Revenue growth: 18.6% vs peer median 6.1%
- faster revenue growth over three years: stronger than 78% of peers. 3-year revenue growth: 17.6% vs peer median 5.8%
Metric by metric
Position: dot = SOPH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SOPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 445 reported | 18.6% | 3.3% | 81% | 33% | |
| Earnings per share growthHigher is better · 225 reported | Not reported | 4.6% | — | — | 33% |
| 3-year revenue growthHigher is better · 423 reported | 17.6% | 3.7% | 79% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around SOPH| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 146 | 156.7B JPY (≈$1.1B) | 61 | 65 | |
| 146 | 3.2B CNY (≈$452M) | 61 | 69 | |
| 150 | 15.6B TWD (≈$485M) | 60 | 49 | |
| 150 | 353M EUR (≈$388M) | 60 | 77 | |
| 150 | 588M USD | 60 | 24 | |
| 153 | 5.1B CNY (≈$719M) | 59 | 74 | |
| 153 | 472M USD | 59 | 33 | |
| 153 | 1.0B USD | 59 | 74 | |
| 156 | 114.7B JPY (≈$780M) | 58 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score